Akoya Biosciences Inc (NAS:AKYA)
$ 3.22 0 (0%) Market Cap: 159.39 Mil Enterprise Value: 199.75 Mil PE Ratio: 0 PB Ratio: 7.16 GF Score: 46/100

Akoya Biosciences Inc at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 01:00PM GMT
Release Date Price: $6.15 (-5.53%)
Kyle Mikson
Canaccord Genuity Group Inc. - Analyst

Good morning. Welcome to the Cannacord Genuity Global Growth Conference. I'm Kyle Mikson. I cover life science tools and diagnostics for Canaccord. And we're pleased to welcome you to this fireside chat with Akoya Biosciences.

Akoya is a leader in the [tissue biology] market, especially in spatial proteomics, offering lots of instruments and consumables. We'll hear more about that today. With us from the company we have Brian McKelligon, CEO; and Johnny Ek, CFO. Thanks for coming, guys. I appreciate it.

Questions & Answers

Kyle Mikson
Canaccord Genuity Group Inc. - Analyst

So maybe, Brian, to start with history of the company basically, and we talk about really how you went from just the early stage of the company, spatial proteomics, the Phenoptics deal, and the now, this push towards multiomics, I guess, then we can wrap it up.

Brian McKelligon
Akoya Biosciences, Inc. - President, CEO, & Director

So yes, the foundation of the company, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot